130 related articles for article (PubMed ID: 38303308)
1. [A Case of Recurrent Breast Cancer That Was BRCA1 Pathogenic Variant-Positive Successfully Treated with PARP Inhibitor].
Aoyagi T; Namura M; Sakata H; Tamanuki T; Iwai M; Iwata K; Takahashi H; Matsuzaki H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1462-1464. PubMed ID: 38303308
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
3. Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variant.
Saito A; Tanioka M; Hirata M; Watanabe T; Odaka Y; Shimoi T; Sudo K; Noguchi E; Ishikawa M; Yonemori K
Cancer Treat Res Commun; 2022; 32():100587. PubMed ID: 35696850
[TBL] [Abstract][Full Text] [Related]
4. Olaparib Keeps Hereditary Breast Tumors in Check.
Cancer Discov; 2017 Aug; 7(8):OF10. PubMed ID: 28583909
[TBL] [Abstract][Full Text] [Related]
5. [A Case Report on the Effectiveness of Olaparib in a Patient with Recurrent Breast Cancer with Human Immunodeficiency Virus Infection].
Yabe S; Iwamoto N; Inokuchi T; Nara M; Saita C; Onishi M; Goto R; Yonekura R; Ishiba T; Honda Y; Miyamoto H; Aruga T
Gan To Kagaku Ryoho; 2020 Jul; 47(7):1089-1092. PubMed ID: 32668858
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Recurrent Breast Cancer with Improving Activities of Daily Living by Olaparib Treatment].
Nakagawa T; Oda G; Okamoto K; Ishikawa T; Wakana K; Oshima N
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1556-1558. PubMed ID: 35046254
[TBL] [Abstract][Full Text] [Related]
7. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
McMullin RP; Wittner BS; Yang C; Denton-Schneider BR; Hicks D; Singavarapu R; Moulis S; Lee J; Akbari MR; Narod SA; Aldape KD; Steeg PS; Ramaswamy S; Sgroi DC
Breast Cancer Res; 2014 Mar; 16(2):R25. PubMed ID: 24625110
[TBL] [Abstract][Full Text] [Related]
8. The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors.
De Soto JA; Wang X; Tominaga Y; Wang RH; Cao L; Qiao W; Li C; Xu X; Skoumbourdis AP; Prindiville SA; Thomas CJ; Deng CX
Int J Biol Sci; 2006; 2(4):179-85. PubMed ID: 16810332
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Ipsilateral Breast Cancer with Contralateral Axillary Node Recurrence after Right Breast Partial Mastectomy].
Adachi M; Hara M; Ishibashi N; Sasaki M; Tomii C; Ohshima N; Koshiishi H; Yoshimura T
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2198-2200. PubMed ID: 33468906
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Pyloric Stenosis Due to Gastric Metastasis of Breast Cancer].
Satoh E; Yatabe Y; Uehira D; Yonekura K; Murakata A; Toyofuku Y; Tanami H; Osanai T; Sugano N; Sakoma T; Maruyama S
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2103-2105. PubMed ID: 35045506
[TBL] [Abstract][Full Text] [Related]
11. An overview of the research progress of BRCA gene mutations in breast cancer.
Wan A; Zhang G; Ma D; Zhang Y; Qi X
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188907. PubMed ID: 37172654
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Brianese RC; Nakamura KDM; Almeida FGDSR; Ramalho RF; Barros BDF; Ferreira ENE; Formiga MNDC; de Andrade VP; de Lima VCC; Carraro DM
Breast Cancer Res Treat; 2018 Feb; 167(3):803-814. PubMed ID: 29116469
[TBL] [Abstract][Full Text] [Related]
13.
Lee A; Moon BI; Kim TH
Ann Lab Med; 2020 Mar; 40(2):114-121. PubMed ID: 31650727
[TBL] [Abstract][Full Text] [Related]
14. Advances in PARP inhibitors for the treatment of breast cancer.
Dizdar O; Arslan C; Altundag K
Expert Opin Pharmacother; 2015; 16(18):2751-8. PubMed ID: 26485111
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Recurrent Breast Cancer with Contralateral Axillary Node Recurrence Cured after Mastectomy for Ipsilateral Breast Tumor Recurrence].
Nakakuma T; Takahashi K; Ueno S; Tabei T; Inada T; Kondou Y; Kosaka Y; Sengoku N
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2018-2020. PubMed ID: 32157045
[TBL] [Abstract][Full Text] [Related]
16. Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy.
Wang X; Hu N; Cui L; Si Y; Yue J; Zheng F; Kang Y; Yuan P
Curr Cancer Drug Targets; 2022; 22(6):530-536. PubMed ID: 35156571
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer.
Secord AA; Barnett JC; Ledermann JA; Peterson BL; Myers ER; Havrilesky LJ
Int J Gynecol Cancer; 2013 Jun; 23(5):846-52. PubMed ID: 23666017
[TBL] [Abstract][Full Text] [Related]
18. Emerging strategies: PARP inhibitors in combination with immune checkpoint blockade in BRCA1 and BRCA2 mutation-associated and triple-negative breast cancer.
Gupta T; Vinayak S; Telli M
Breast Cancer Res Treat; 2023 Jan; 197(1):51-56. PubMed ID: 36318381
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Recurrent Breast Cancer with Multiple Bone Metastasis Effectively Treated by CDK4/6 Inhibitor in Addition to Aromatase Inhibitor].
Satoh E; Hara M; Uehira D; Yonekura K; Murakata A; Ohinata R; Toyofuku Y; Tanami H; Osanai T; Sugano N; Sakoma T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1491-1493. PubMed ID: 36733112
[TBL] [Abstract][Full Text] [Related]
20. Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults.
Watanabe T; Honda T; Totsuka H; Yoshida M; Tanioka M; Shiraishi K; Shimada Y; Arai E; Ushiama M; Tamura K; Yoshida T; Kanai Y; Kohno T
Breast Cancer Res Treat; 2020 Jul; 182(2):491-502. PubMed ID: 32488393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]